- 全部删除
- 您的购物车当前为空
Tauroursocholic acid (TUCA) 是一种牛磺酸结合形式的胆汁酸,源自ursocholic acid,并为taurocholic acid (TCA) 的7β-hydroxy对映体。与TCA不同,TUCA不抑制HMG-CoA reductase或细胞色素P450 (CYP) 异构体CYP7A1,即胆固醇7α-hydroxylase。在胆管癌患者中,TUCA的胆汁水平高于良性胆道疾病患者。
Tauroursocholic acid (TUCA) 是一种牛磺酸结合形式的胆汁酸,源自ursocholic acid,并为taurocholic acid (TCA) 的7β-hydroxy对映体。与TCA不同,TUCA不抑制HMG-CoA reductase或细胞色素P450 (CYP) 异构体CYP7A1,即胆固醇7α-hydroxylase。在胆管癌患者中,TUCA的胆汁水平高于良性胆道疾病患者。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | Tauroursocholic acid (TUCA) is the taurine-conjugated derivative of ursocholic acid and serves as the 7β-hydroxy epimer of taurocholic acid (TCA). Unlike TCA, TUCA does not inhibit HMG-CoA reductase or the cytochrome P450 (CYP) isoform CYP7A1, also known as cholesterol 7α-hydroxylase. Elevated bile levels of TUCA are observed in patients with biliary tract cancer compared to those with benign biliary conditions. |
别名 | TUCA |
分子量 | 537.69 |
分子式 | C26H44NNaO7S |
CAS No. | 17515-36-5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容